Morbidly adherent placenta (MAP) can be associated with major maternal morbidity, and is increasing in frequency. Determination of optimal management has not yet been satisfactory. We identify problems with lack of uniformity and the need for standardized nomenclature for the diagnosis, treatment and research of MAP. We suggest potential solutions and identify areas of future work.
Overview
Morbidly adherent placenta (MAP) occurs when the placenta fails to detach from the uterine wall due to abnormal implantation at the basal plate. This often leads to massive obstetric hemorrhage, and sequelae such as blood transfusion, multi-organ failure, need for morbid hysterectomy, and even death 1 . Owing to the relative rarity of the condition, few high quality data are available regarding the optimal management. However, it is increasing in frequency 2, 3 and has become one of the most morbid obstetric disorders in developed nations [2] [3] [4] [5] [6] [7] . This is likely due to a dramatic and persistent increase in the rate of cesarean delivery [2] [3] [4] [5] [6] [7] [8] . Determination of optimal management has been further hampered by a lack of standard nomenclature.
Some definitions are clinical, others based on imaging, and still others based on histopathology. However, there is considerable variation among the definitions used among countries, regions, hospitals and even clinicians. Cases of MAP managed conservatively (without hysterectomy) are hard to define since there is no specimen to evaluate histologically. Consequently, it is difficult to compare results of studies and to improve care for women with MAP.
This problem is highlighted by studies on the conservative management of MAP.
Excellent outcomes have been reported after hysterotomy, leaving the placenta in-situ, partial removal of the placenta, or removal of the placenta with additional hemostatic suturing of the placental bed. However, none of these cases had confirmed placenta accreta spectrum based on histological examination. Thus, it is difficult to counsel women regarding the true risks of conservative management of MAP. Many of these women had fewer traditional risk factors for MAP (such as multiple prior cesareans) than in other series. Accordingly, their outcomes may not be applicable to women with multiple prior cesarean sections and placenta previa.
Accurate prenatal diagnosis is critical to reduce the risk of maternal morbidity and mortality. Indeed, several studies have reported that antenatal diagnosis of MAP leads to reduced blood loss and other complications [9] [10] [11] . In part, this is due to planned cesarean hysterectomy, delivery of the infant through a fundal hysterotomy and avoidance of the placenta. In addition, it allows for planned delivery under optimal circumstances in a center of excellence skilled in the delivery of women with MAP 12 .
Unfortunately, the ability to antenatally diagnose MAP is imperfect, in part due to a 4 lack of uniform nomenclature and significant overlap of ultrasound markers of MAP with normally implanted placentas.
There are numerous reports on prenatal diagnosis of invasive placentation using ultrasound 13 . In fact, relatively high sensitivities and specificities have been described, albeit in high-risk cases and with full knowledge of clinical risk factors.
Unfortunately, there is low consistency in the terminology used to describe the sonographic features of MAP. In turn, this makes it difficult to compare studies of sonographically diagnosed MAP. In addition, there are substantial clinical implications since failure to diagnose MAP may lead to avoidable morbidity while false positive diagnoses may result in unnecessary hysterectomies and loss of fertility.
Clearly there is a need for standardized nomenclature when it comes to the diagnosis, treatment and research of MAP.
Issues with antenatal diagnosis of invasive placentation
Ultrasound features of invasive placentation have been described and can be divided into the following groups:
a. Direct visualization of placental tissue beyond the uterine cavity, such as a bulging mass in the urinary bladder. Although visualization of the placenta in the bladder cavity is strong evidence of abnormal placental invasion, this is a rare finding. Consequently, the sensitivity is low, but specificity is high.
Overall, the prevalence of this sign in cases of confirmed invasive placentation is very low.
b. Abnormalities of the placental-uterine interface. Using gray scale ultrasound, loss of the normal hypo-echoic retro-placental space has been described as a sign of MAP. This feature is however, operator and angle dependent, varies between an anterior or posterior placenta and is associated with a high false positive rate.
c. Lower segment myometrial thickness. The myometrial thickness in the lower segment is measurable in millimeters. A study of 30 women with previous
Caesarean delivery using both trans-abdominal and transvaginal ultrasound between 36 and 39 weeks of gestation, reported the thickness of the entire lower uterine segment to be 3.6 -19.2 mm, and 1.0-9.7 mm, respectively. The 95% limits of agreement were 3.5 mm and 0.8 mm, respectively. This metric is poorly reproducible and subject to considerable variation 14 . The sign has been described in many cases without invasive placentation, and the observed specificity is low 15 .
d. Color Doppler studies. Using color Doppler ultrasound, increased vascularity of the lower segment-urinary bladder interface has been described (Table 1) 
Problems with ascertainment of invasive placentation
There are two main theoretical approaches to the definitive ascertainment of MAP.
One is histopathological confirmation, and the other is based on surgical findings.
Both are problematic for different reasons.
Placental Histological Examination
Most cases of MAP are due to placenta accreta spectrum, representing different grades of morbid placental attachment secondary to invasion of placental tissue deep into the myometrium beyond the normal utero-placental interface. Placenta accreta is histologically defined as placental attachment to the myometrium without intervening decidua. If there is deep myometrial invasion it is termed placenta increta and if invasion through myometrium into the serosa and beyond, even into surrounding structures such as the bladder, it is termed percreta. The term placenta accreta spectrum also is often used in cases of clinically apparent morbidly adherent placenta.
Placenta accreta is often simplistically defined as invasion of the myometrium with placental villi in contact with myometrial tissue. However, the main histological feature is the absence of normal decidua at the basal plate, and the detection of such findings is dependent on the mode of placental delivery and sampling issues. In one study microscopic foci of myometrial tissue adherent to the basal plate with deficient 7 intervening decidua, consistent with a mild or focal form of placenta accreta, were described in 36 placentas, of which only four had a clinical diagnosis of placenta accreta, none requiring hysterectomy 27 . It was concluded that mild cases of placenta accreta are frequently associated with previous uterine operations and multiparity, and are clinically suspected only infrequently. Similar findings were also reported in 44 of 457 (9.6%) preterm (birth < 32 weeks) placentas, with basal plate myometrial fibres present 28 and in another study of 90 consecutive singleton placentas basal plate myometrial fibers were seen in 27/90 (30%) 29 . Only 9 of these 27 had clinical features suggestive of placenta accreta, such as postpartum hemorrhage, delayed third stage of labor, retained placenta, or need for manual removal. The high frequency of myometrial fibers were attributed to extensive sampling and it was suggested that myometrial fibers in the placental basal plate can confirm, but do not necessarily indicate clinical placenta accreta.
Conversely, conservative surgery may leave residual adherent parts of the placenta insitu and therefore histopathological confirmation will not be possible. Moreover, the pathologist is more likely to seek invasive placentation if extirpative surgery has been performed whereas features of MAP may be missed if the pathologist only assesses a small number of routine placental sections. Furthermore, practice and expertise among pathologists varies considerably and there is no "standard" approach for assessment and diagnosis of MAP. It is now generally agreed that histologically, the characteristic feature of invasive placentation is not only the close localization of villi and myometrium, but rather the histological lack of decidua between chorionic villi and myometrium, often with only fibrin intervening. We are not aware of any blinded studies or indeed any studies which have examined the effects of sampling on false negatives in true cases.
Clinical Diagnosis:
Placental tissue may be seen at the site of the surgical scar on direct visualization 25 . It may be argued that the picture resembles the fetal surface of the placenta, whereas one expects to see the maternal surface. It is not always easy to tell where the placenta ends and the myometrium begins. A vascular lower segment in a case of anterior placenta previa may well be indistinguishable from 'placenta in the scar'.
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A diagnosis of MAP also is made when the placenta is adherent to the uterus and does not easily detach, however, again this is subjective, with no clear distinction between MAP and "retained placenta" in many cases. There are no objective criteria for the clinical diagnosis of MAP. The ultimate aim is prediction of major morbidity, whether or not invasive placentation is confirmed on histopathology or at surgery.
Future directions
Identification of at risk women: Several risk factors for invasive placentation have been described.
There is accumulating evidence to suggest that a Caesarean scar pregnancy detected in the first trimester is a precursor of MAP [30] [31] [32] [33] . There is a lack of agreement regarding the most appropriate diagnostic criteria for Caesarean scar pregnancy 34 .
However, a high proportion of Caesarean scar pregnancies result in morbidly adherent placenta in the absence of intervention [35] [36] [37] . This is not inevitable though, as uncomplicated pregnancy and delivery has been reported following conservative management of Caesarean scar pregnancy 34 .
In the second half of pregnancy, the most common and clinically important risk factor is the combination of placenta previa and previous lower segment Caesarean delivery.
Uterine surgery such as myomectomy, curettage or endometrial resection/ablation also increases the risk, but it is often difficult to know the exact site of the previous injury, although reports of prenatal diagnosis of fundal placenta accreta have been published. In such cases it is possible to deliver the infant without disturbing the placenta and deal with the placenta later. Hemostasis is likely to be easier, and parametrial structures are not directly at risk. In a series of 187 women with placenta previa and previous uterine surgery, 46 (24.6%) had previous myomectomy and 23 (12.3%) had prior curettage, but none had confirmed MAP 25 . The greatest yield of risk factors seems to be women with presence of placenta in the anterior lower segment with previous lower segment scar.
Agreement on standard operating procedure for evaluation of women:
It is unclear if women should be examined with empty, partly filled or full urinary bladder, and if trans-abdominal or transvaginal scan should be used. Prospective studies should be directed to collect data by examining women abdominally as well as using TV 9 scan, and with and without bladder filling in all cases, also assessing possible parametrial extension on ultrasound. The most appropriate gestational age at which assessment should be performed is also unclear. Table 3 ). The terminology deliberately avoids the term 'accreta'. As already mentioned, the aim is to identify disorders associated with major maternal morbidity/mortality.
Use of MRI:
Whilst definitive antenatal diagnosis may not be possible, by developing scoring systems and assigning weight to individual signs depending on their positive likelihood ratios, improved detection and management should be possible. Such future developments should be on the basis of robust data rather than logic, reasoning or consensus of 'experts'. 2010 Vessels crossing the interface disruption site Attempt at removal of the placenta leads to brisk hemo Placenta seen to be permeating the full thickness of urinary bladder or parametrium.
Legends to figures
Pathology definition/criteria Histological lack of decidua between chorionic villi a intervening.
Close localisation of villi and myometrium can be an a
